Summary
This 2024 study employed multiplex proteomics of cerebrospinal fluid to identify protein biomarkers for Alzheimer's disease diagnosis and prediction of cognitive decline. The findings suggest that specific CSF protein signatures may improve early detection and risk stratification for dementia. The work contributes to emerging neurobiological understanding of Alzheimer's aetiology, though direct links to dietary and farming-system interventions remain indirect.
Regional applicability
The biomarkers identified could support clinical diagnosis in UK dementia services, though implementation would require integration into existing NHS diagnostic pathways and specialist centres. The findings do not directly address UK agricultural or nutritional policy, but may inform future research on dietary factors and neuroinflammatory mechanisms in dementia prevention.
Key measures
CSF protein biomarkers; cognitive decline trajectories; diagnostic accuracy; prognostic performance; receiver operating characteristic (ROC) curves
Outcomes reported
The study identified multiplex cerebrospinal fluid (CSF) protein biomarkers for Alzheimer's disease diagnosis and prediction of cognitive decline. Proteomic profiling was used to distinguish Alzheimer's disease cases from controls and to forecast progression in at-risk populations.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.